Rajiv de Silva, President & COO, Specialty Pharm at Valeant Pharmaceuticals International, Inc. (VRX), sold 76,344 shares at $54.04 ($4.1M) on 2012-11-08, disclosed to the SEC on 2012-11-09.
Open-market sale of $4.1M VRX by President & COO, Specialty Pharm. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ENDP | BUY | 2015-11-12 | $500K | — | Filing → |
| VRX | SELL | 2012-11-08 | $12.0M | — | Filing → |
| VRX | BUY | 2011-08-16 | $250K | — | Filing → |